Rated 3.7 / 5 (How Ratings Work)
Likely probability of the efficacy of cannabis for treatment of chemotherapy-induced nausea and vomiting.
Based on 42 Studies from 1975 - 2017
Study Name, Description & Year
Rating
Experts' Perspectives On The Role Of Medical Marijuana In Oncology: A Semistructured Interview Study
Review of 15 academic experts in the filed of oncology and medical cannabis interface. — 2017
Efficacy, Tolerability, And Safety Of Cannabinoids For Chemotherapy-induced Nausea And Vomiting--a Systematic Review Of Systematic Reviews
Meta-analysis — 2016
Antiemetic Medication For Prevention And Treatment Of Chemotherapy-induced Nausea And Vomiting In Childhood
Review — 2016
Controlled Release Tablet Formulation Containing Natural Δ(9)-tetrahydrocannabinol
Laboratory Study — 2016
Meta-analysis Of Adjunctive Non-NK1 Receptor Antagonist Medications For The Control Of Acute And Delayed Chemotherapy-induced Nausea And Vomiting
Meta-analysis — 2015
Endocannabinoid Mechanisms Influencing Nausea
Review — 2015
Endocannabinoid Mechanisms Influencing Nausea
Review — 2015
Therapeutic Potential Of Cannabinoids In Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review
Review — 2015
Preliminary Efficacy And Safety Of An Oromucosal Standardized Cannabis Extract In Chemotherapy-induced Nausea And Vomiting
A randomized, double-blind, placebo-controlled trial conducted on 16 patients undergoing chemotherapy — 2010
Cannabidiol Attenuates Cisplatin-induced Nephrotoxicity By Decreasing Oxidative/nitrosative Stress, Inflammation, And Cell Death
Animal study (mice) — 2009
Efficacy Of Dronabinol Alone And In Combination With Ondansetron Versus Ondansetron Alone For Delayed Chemotherapy-induced Nausea And Vomiting
64 cancer patients undergoing chemotherapy — 2007
Established And Potential Therapeutic Applications Of Cannabinoids In Oncology
Review of selective studies — 2003
Cannabinoids For Control Of Chemotherapy Induced Nausea And Vomiting: Quantitative Systematic Review
Review of selective studies — 2001
An Efficient New Cannabinoid Antiemetic In Pediatric Oncology
Children with cancer receiving chemotherapy — 1995
Dronabinol And Prochlorperazine In Combination For Treatment Of Cancer Chemotherapy-induced Nausea And Vomiting
67 cancer patients undergoing chemotherapy — 1991
A Randomized Trial Of Oral Nabilone And Prochlorperazine Compared To Intravenous Metoclopramide And Dexamethasone In The Treatment Of Nausea And Vomiting Induced By Chemotherapy Regimens Containing Cisplatin Or Cisplatin Analogues
Chemotherapy patients — 1988
Efficacy Of Tetrahydrocannabinol In Patients Refractory To Standard Antiemetic Therapy
36 cancer patients undergoing chemotherapy where pharmaceutical emetics were ineffective — 1988
Inhalation Marijuana As An Antiemetic For Cancer Chemotherapy
56 cancer patients undergoing chemo-therapy unresponsive to standard anti-emetic drugs — 1988
Nabilone Versus Prochlorperazine For Control Of Cancer Chemotherapy-induced Emesis In Children: A Double-blind, Crossover Trial
Pediatric chemotherapy patients — 1987
A Double-blind Randomised Cross-over Comparison Of Nabilone And Metoclopramide In The Control Of Radiation-induced Nausea
Patients under-going radiation therapy — 1987
Nabilone And Metoclopramide In The Treatment Of Nausea And Vomiting Due To Cisplatinum: A Double-blind Study
32 cancer patients undergoing chemotherapy — 1986
Nabilone: An Alternative Antiemetic For Cancer Chemotherapy
18 pediatric patients — 1986
Prospective Randomized Double-blind Trial Of Nabilone Versus Domperidone In The Treatment Of Cytotoxic-induced Emesis
38 cancer patients receiving chemotherapy — 1986
A Cross-over Comparison Of Nabilone And Prochlorperazine For Emesis Induced By Cancer Chemotherapy
24 lung cancer patients receiving chemotherapy — 1985
Anti-emetic Efficacy And Toxicity Of Nabilone, A Synthetic Cannabinoid, In Lung Cancer Chemotherapy
34 patients with lung cancer — 1983
[Randomized Comparative Trial Of A New Anti-emetic: Nabilone, In Cancer Patients Treated With Cisplatin]
20 patients with advanced gynecological cancer — 1983
A Randomised Multicentre Single Blind Comparison Of A Cannabinoid Anti-emetic (levonantradol) With Chlorpromazine In Patients Receiving Their First Cytotoxic Chemotherapy
108 cancer patients — 1983
Cannabis And Cancer Chemotherapy: A Comparison Of Oral Delta-9-THC And Prochlorperazine
212 cancer patients undergoing chemotherapies — 1982
A Double-blind, Controlled Trial Of Nabilone Vs. Prochlorperazine For Refractory Emesis Induced By Cancer Chemotherapy
27 cancer patients undergoing chemotherapy who failed to respond to pharmacological anti-emetics — 1982
A Multi-institutional Phase III Study Of Nabilone Vs. Placebo In Chemotherapy-induced Nausea And Vomiting
24 cancer patients undergoing chemotherapy — 1982
Antiemetic Effect Of Delta 9-tetrahydrocannabinol In Chemotherapy-associated Nausea And Emesis As Compared To Placebo And Compazine
55 chemotherapy patients — 1981
Superiority Of Nabilone Over Prochlorperazine As An Antiemetic In Patients Receiving Cancer Chemotherapy
113 cancer chemotherapy patients — 1979
Antiemetic Effect Of Delta-9-tetrahydrocannabinol In Patients Receiving Cancer Chemotherapy
20 cancer chemotherapy patients — 1975